Literature DB >> 17709553

Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.

Wassim M Ballan1, Bien-Aimee N Vu, Brian R Long, Christopher P Loo, Jakob Michaëlsson, Jason D Barbour, Lewis L Lanier, Andrew A Wiznia, Jacobo Abadi, Glenn J Fennelly, Michael G Rosenberg, Douglas F Nixon.   

Abstract

NK cells play an integral role in the innate immune response by targeting virally infected and transformed cells with direct killing and providing help to adaptive responses through cytokine secretion. Whereas recent studies have focused on NK cells in HIV-1-infected adults, the role of NK cells in perinatally HIV-1-infected children is less studied. Using multiparametric flow cytometric analysis, we assessed the number, phenotype, and function of NK cell subsets in the peripheral blood of perinatally HIV-1-infected children on highly active antiretroviral therapy and compared them to perinatally exposed but uninfected children. We observed an increased frequency of NK cells expressing inhibitory killer Ig-like receptors in infected children. This difference existed despite comparable levels of total NK cells and NK cell subpopulations between the two groups. Additionally, NK cell subsets from infected children expressed, with and without stimulation, significantly lower levels of the degranulation marker CD107, which correlates with NK cell cytotoxicity. Lastly, increased expression of KIR2DL3, NKG2C, and NKp46 on NK cells correlated with decreased CD4+ T-lymphocyte percentage, an indicator of disease severity in HIV-1- infected children. Taken together, these results show that HIV-1-infected children retain a large population of cytotoxically dysfunctional NK cells relative to perinatally exposed uninfected children. This reduced function appears concurrently with distinct NK cell surface receptor expression and is associated with a loss of CD4+ T cells. This finding suggests that NK cells may have an important role in HIV-1 disease pathogenesis in HIV-1-infected children.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17709553      PMCID: PMC4271645          DOI: 10.4049/jimmunol.179.5.3362

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  73 in total

1.  Characterization of lymphocyte subpopulations in cord blood.

Authors:  C Rabian-Herzog; S Lesage; E Gluckman
Journal:  Bone Marrow Transplant       Date:  1992       Impact factor: 5.483

2.  Detection of T-cell degranulation: CD107a and b.

Authors:  Michael R Betts; Richard A Koup
Journal:  Methods Cell Biol       Date:  2004       Impact factor: 1.441

3.  Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection.

Authors:  Galit Alter; Nickolas Teigen; Benjamin T Davis; Marylyn M Addo; Todd J Suscovich; Michael T Waring; Hendrik Streeck; Mary N Johnston; Kyle D Staller; M Tauheed Zaman; Xu G Yu; Mathias Lichterfeld; Nesli Basgoz; Eric S Rosenberg; Marcus Altfeld
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

4.  Natural killer cell activity in very low birth weight infants.

Authors:  T McDonald; J Sneed; W R Valenski; M Dockter; R Cooke; H G Herrod
Journal:  Pediatr Res       Date:  1992-04       Impact factor: 3.756

5.  Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells.

Authors:  Jason M Brenchley; Nitin J Karandikar; Michael R Betts; David R Ambrozak; Brenna J Hill; Laura E Crotty; Joseph P Casazza; Janaki Kuruppu; Stephen A Migueles; Mark Connors; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

Review 6.  Antibody-dependent cellular cytotoxicity in HIV infections.

Authors:  A Ahmad; J Menezes
Journal:  FASEB J       Date:  1996-02       Impact factor: 5.191

7.  HIV-1-specific cytotoxic T lymphocyte responses in the first year of life.

Authors:  K Luzuriaga; D Holmes; A Hereema; J Wong; D L Panicali; J L Sullivan
Journal:  J Immunol       Date:  1995-01-01       Impact factor: 5.422

8.  Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone.

Authors:  M R Goodier; N Imami; G Moyle; B Gazzard; F Gotch
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

9.  CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction.

Authors:  Piotr Trzonkowski; Ewa Szmit; Jolanta Myśliwska; Anita Dobyszuk; Andrzej Myśliwski
Journal:  Clin Immunol       Date:  2004-09       Impact factor: 3.969

Review 10.  Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression.

Authors:  Jason D Barbour; Uma Sriram; Stacy J Caillier; Jay A Levy; Frederick M Hecht; Jorge R Oksenberg
Journal:  PLoS Pathog       Date:  2007-04       Impact factor: 6.823

View more
  34 in total

1.  NKG2C deletion is a risk factor of HIV infection.

Authors:  Rachel Thomas; Hui Zhi Low; Katja Kniesch; Roland Jacobs; Reinhold E Schmidt; Torsten Witte
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-03       Impact factor: 2.205

2.  Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users.

Authors:  Costin Tomescu; Fuh-Mei Duh; Michael A Lanier; Angela Kapalko; Karam C Mounzer; Maureen P Martin; Mary Carrington; David S Metzger; Luis J Montaner
Journal:  AIDS       Date:  2010-09-10       Impact factor: 4.177

3.  Association of KIR3DL1/S1 and HLA-Bw4 with CD4 T cell counts in HIV-infected Mexican mestizos.

Authors:  Daniel Hernández-Ramírez; Mario A Esparza-Pérez; José L Ramirez-Garcialuna; J Rafael Arguello; Peter B Mandeville; Daniel E Noyola; Christian A García-Sepúlveda
Journal:  Immunogenetics       Date:  2015-06-03       Impact factor: 2.846

4.  S100A14 Is Increased in Activated NK Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte-NK Crosstalk.

Authors:  Krystal Colón; David W Speicher; Peter Smith; Mack Taylor; David S Metzger; Luis J Montaner; Costin Tomescu
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

5.  Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD.

Authors:  Silke Wiesmayr; Steven A Webber; Camila Macedo; Iulia Popescu; Louise Smith; Jane Luce; Diana Metes
Journal:  Eur J Immunol       Date:  2011-12-16       Impact factor: 5.532

Review 6.  Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).

Authors:  C Tomescu; S Abdulhaqq; L J Montaner
Journal:  Clin Exp Immunol       Date:  2011-03-17       Impact factor: 4.330

7.  The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.

Authors:  Stephanie M Dillon; Eric J Lee; Julia M Bramante; Edward Barker; Cara C Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2014-03-01       Impact factor: 3.731

8.  Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection.

Authors:  Lishomwa C Ndhlovu; Joan M Chapman; Aashish R Jha; Jennifer E Snyder-Cappione; Moraima Pagán; Fabio E Leal; Brigid S Boland; Philip J Norris; Michael G Rosenberg; Douglas F Nixon
Journal:  AIDS       Date:  2008-05-11       Impact factor: 4.177

9.  Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in simian immunodeficiency virus-infected rhesus macaques with high viral loads.

Authors:  Pavel Bostik; Jaruda Kobkitjaroen; Weining Tang; Francois Villinger; Lara E Pereira; Dawn M Little; Susan T Stephenson; Mark Bouzyk; Aftab A Ansari
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

10.  Infection with Vpr-positive human immunodeficiency virus type 1 impairs NK cell function indirectly through cytokine dysregulation of infected target cells.

Authors:  Biswanath Majumder; Narasimhan J Venkatachari; Shaylee O'Leary; Velpandi Ayyavoo
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.